BWAY - Brainsway Ltd.

12.71
0.050   0.393%

Share volume: 195,087
Last Updated: 03-10-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$12.66
0.05
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
13%
Profitability 0%
Dept financing 19%
Liquidity 31%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.00%
1 Month
-45.75%
3 Months
-27.04%
6 Months
-19.04%
1 Year
32.12%
2 Year
103.36%
Key data
Stock price
$12.71
P/E Ratio 
0.00
DAY RANGE
$12.38 - $12.97
EPS 
-$0.32
52 WEEK RANGE
$7.84 - $26.63
52 WEEK CHANGE
$23.40
MARKET CAP 
107.093 M
YIELD 
N/A
SHARES OUTSTANDING 
16.678 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
1.83
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$136,781
AVERAGE 30 VOLUME 
$104,287
Company detail
CEO: Christopher R. von Jako
Region: US
Website: brainsway.com
Employees: 120
IPO year: 2019
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry.

Recent news